Quantcast
Channel: ADVM – Open Reading Frame
Browsing all 2 articles
Browse latest View live

Image may be NSFW.
Clik here to view.

Biotech portfolio updates – Exelixis, Spark, buying more gene therapy stocks

Exelixis – Decreasing exposure on valuation Exelixis (EXEL) continues to look very strong after hitting a 15-year high on Friday, which is never a bad point in time to realize some gains. While I still...

View Article



Image may be NSFW.
Clik here to view.

Gene therapy’s 2017 scorecard – No alarms and no surprises (please)

Readers of this blog know I have high hopes for gene therapy, a field with a checkered history but disruptive potential that may finally be ready for primetime. After two years of dramatic progress...

View Article
Browsing all 2 articles
Browse latest View live




Latest Images